Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from diabetes

Diabetes and dementia: The surprising link revealed by new research

The link between diabetes and dementia is becoming increasingly clear.

The Independent UK

Ten ways diabetes and dementia are linked

The link between diabetes and dementia is becoming increasingly clear. New research shows how blood sugar problems affect brain health and vice versa. Here are ten evidence-based insights into how the two conditions are related.

The Conversation

Kathy Bates shares update on health difficulties after 100-pound weight loss

The actor began her weight loss journey after being diagnosed with diabetes in 2017

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Thousands at risk of invalidating travel insurance by using weight-loss jabs

About one-fifth of people incorrectly think weight-loss jabs are a lifestyle or cosmetic tool instead of a medical treatment

The Independent UK

Novo Nordisk, maker of obesity drug Wegovy, to cut 9,000 jobs to sharpen focus, meet competition

Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the company’s focus on growth opportunities in obesity and diabetes medications

The Independent UK

Millions of people with diabetes do not know they have it. What are the signs?

People with diabetes were most likely to be diagnosed in high-income North America, and most likely to be treated in high-income Asia Pacific.

Euronews

Wegovy maker Novo Nordisk to cut 9,000 jobs amid increased competition

Danish manufacturer of weight-loss and diabetes drugs under pressure from US rival Eli Lilly

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

Scientists Reveal Eating Cherries in THIS Way Can Help Prevent Major Illness Affecting 6.7m Americans

New research highlights cherries as a nutrient-packed fruit that may lower the risk of heart disease, stroke and type 2 diabetes if consumed daily.

International Business Times UK

Study finds millions of people live with undiagnosed diabetes

IN FULL

The Independent UK

Almost half of those with diabetes don’t know they have it. Are you one of them?

Diabetes affects 38.4 million Americans, according to the Centers for Disease Control and Prevention

The Independent UK

UK ‘falling behind’ when it comes to diabetes diagnosis, study says

Among western European countries, only Switzerland and France had lower diagnosis rates than the UK

The Independent UK

UK diabetes diagnosis rates lag behind other high-income countries

Some 74.2% of people with the condition were estimated to have been diagnosed in the UK.

The Independent UK

Ozempic Is The New Botox And Big Pharma Is Printing Billions

Ozempic and Zepbound have morphed from diabetes treatment into a cultural phenomenon, helping Novo Nordisk A/S (NYSE:NVO) and Eli Lilly And Co (NYSE:LLY) achieve a combined market cap topping $900 billion. Celebrities flaunt it, Silicon Valley elites swear by it, and analysts predict the GLP-1 market could surpass $150 billion…

Benzinga

Researchers find new link between women who suffer heart attacks

The typical risk factors for major cardiovascular events include high blood pressure, high cholesterol, diabetes, or a history of smoking

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

WHO has added GLP-1 drugs to the essential medicines list. Here’s what that means

GLP-1 drugs were initially developed for diabetes, but have become wildly popular weight-loss drugs too

The Independent UK

Some NHS patients wrongly diagnosed with type 2 diabetes

IN FULL

International Business Times

WHO Backs Weight-loss Drugs, Urges Cheap Generics

The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made available for people in developing countries.

The Independent UK

Error means 55,000 patients require diabetes retests after potential misdiagnoses

More than 55,000 patients may require new blood tests to receive an accurate blood glucose reading

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

‘Artificial pancreas’ to be given to women with diabetes to cut pregnancy risks

Mothers-to-be with the condition have higher risks as pregnancy hormones can make it harder for them to regulate their blood glucose levels.

The Independent UK

New technology for diabetic pregnant women will reduce risk of miscarriage and stillbirth

The new technology, known as a hybrid closed loop system, will help reduce the risk of stillbirth and miscarriage

International Business Times

From Diagnosis to Advocacy: How Dr. Keith Hersey is Guiding Patients Through Diabetes and GLP-1 Therapy

Hersey is slated to speak at an international conference in Orlando and will address a local diabetes support group in Raleigh on October 1.

The Independent UK

RFK Jr, who doesn’t have a medical degree, says he can diagnose children just by just looking at them

Kennedy has often raised concerns about the increasing juvenile diabetes and autism rates

Benzinga

UK Patients Scramble For Mounjaro As Eli Lilly's 170% Price Hike Plan Sparks Shortages, Health Fears

Patients across the United Kingdom are struggling to obtain the weight-loss and diabetes drug Mounjaro as demand surges ahead of a sharp price increase set for September.

The Independent UK

Daily weight loss pill achieves main goal in late-stage trial

Data from an earlier study of the drug in patients without diabetes sent company shares tumbling

Benzinga

Eli Lilly's Obesity Pill Shows Big Wins In Weight, Blood Sugar And Heart Risk Factors

Eli Lilly and Co. (NYSE:LLY) on Tuesday released topline results from the Phase 3 ATTAIN-2 trial, evaluating oral orforglipron in adults with obesity or overweight and type 2 diabetes.

1 … 13 14 15 16

People

Madeline Matty Matlock

19 stories

Ian Hughes

11 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

the Centers for Disease Control and Prevention

224 stories

the World Health Organisation

the University of Exeter

108 stories

Eli Lilly And Co

55 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.